4//SEC Filing
NABI BIOPHARMACEUTICALS 4
Accession 0001206466-03-000010
$VXRTCIK 0000072444operating
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 3:54 PM ET
Size
6.5 KB
Accession
0001206466-03-000010
Insider Transaction Report
Form 4
GURY DAVID J
Director
Transactions
- Sale
Common Stock
2003-11-06$11.30/sh−4,000$45,200→ 548,158.581 total - Sale
Common Stock
2003-11-07$11.30/sh−4,578$51,731→ 543,580.581 total
Holdings
- 113,400(indirect: By immediate family)
Common Stock
- 1,500(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 3:54 PM ET
- Size
- 6.5 KB